Brachytherapy boost (BT-boost) or stereotactic body radiation therapy boost (SBRT-boost) for high-risk prostate cancer (HR-PCa)

Cancer shared this article with you from Inoreader Brachytherapy boost (BT-boost) or stereotactic body radiation therapy boost (SBRT-boost) for high-risk prostate cancer (HR-PCa) Via Cancer/Radiothérapie Publication date: Available online 18 January 2021 Source: Cancer/Radiothérapie Author(s): G. Peyraga, T. Lizee, J. Khalifa, E. Blais, G. Mauriange-Turpin, S. Supiot, S. Krhili, P. Tremolieres, P. Graff-Cailleaud View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.